Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001
Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001
Thrombolytic Therapy in Patients with Acute Ischemic Stroke
Arch Neurol 57:1430-1436, Hinchey,J.A. & Benesch,C., 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000
Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000
Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Intravenous Valproate is Well Tolerated in Unstable Patients with Status Epilepticus
Neurol 55:722-724, Sinha,S. & Naritoku,D.K., 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
Multifocal Motor Neuropathy Improved by IVIg
Neurol 55:1256-1262,1246, Federico,P.,et al, 2000
Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000
Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000
Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000
rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000
Treatment of Acute Disseminated Encephaloymelitis with Intravenous Immunoglobulin
Neurol 54:1370-1372, Sahlas,D.J.,et al, 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000
Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999
Pompholyx (Vesicular Eczema) After IV Immunoglobulin Therapy for Neurologic Disease
Neurol 53:1154-1155, Iannaccone,S.,et al, 1999
Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Therapeutic Plasma Exchange and Intravenous Immunoglobulin for Obsessive-Compulsive Disorder and Tic Disorders in Childhood
Lancet 354:1153-1158, Perlmutter,S.J.,et al, 1999
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999